Matching geography
Reports matching your search in:
 
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 
Region: All Regions > South America
Category: All Categories > Life Sciences > Pharmaceuticals > Manufacturing, Packaging & Detailing
(100 reports matching your criteria)
< prev 1    3  4  
Pharmaceuticals and Healthcare Report - Argentina Q4 2014
8/27/2014 | published by: Business Monitor International
... erode the growth ofthe country's pharmaceutical market. More foreign pharmaceutical companies will cease their localoperations, if the hostile business environment is worsened. Headline Expenditure Projections Pharmaceuticals: ARS39.30bn (USD7.18 bn) in 2013 to ARS50.10bn (USD6.04bn) in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Colombia Q4 2014
8/27/2014 | published by: Business Monitor International
... bioequivalence regulationswill also undermine sale growth posted by branded generic drugmakers. However, Colombia's relativelyadvanced drug reimbursement system will still offer revenue-generating opportunities for multinationals incomparison with other second-tier Latin American pharmaceutical markets. Headline Expenditure Projections ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Venezuela Q3 2014
7/11/2014 | published by: Business Monitor International
... market until the end of President Maduro's first term. Headline Expenditure Projections Pharmaceuticals: VEB59.85bn (USD9.85bn) in 2013 to VEB88.73bn (USD10.09bn) in 2014; +48.2%in local currency terms and 2.4% in US dollar terms. Forecast revised upwards ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Chile Q3 2014
7/2/2014 | published by: Business Monitor International
... of insurance and clinicmanagement business units. Chile's slightly deteriorating business environment will also put pressure onfuture financial performance. Multinationals will also face further challenges due to the promotion ofgeneric drug usage in Chile. Headline Expenditure ...  |  read more...
USD 1,295
Uruguay Analgesics
6/12/2014 | published by: Euromonitor International
... report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2009-2013, allowing you to identify the sectors driving growth. Forecasts to ...  |  read more...
USD 900
Pharmaceuticals and Healthcare : Brazil Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
... improving regulatory regimeand significant private healthcare growth mean that the market presents significant revenue-generatingopportunities for drugmakers and healthcare service providers. However, multinationals will continue toface increasing drug pricing pressure and domestic competition. Headline Expenditure Projections ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Peru Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
... the country due to the lack of a mandatorymedicine pricing system in the country. More stringent quality control, a relatively weak domesticpharmaceutical industry, the ongoing liberalisation of bilateral trade agreements and the healthcare reformas well ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Argentina Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
... in the pharmaceutical industry. The localpharmaceutical market and healthcare system will continue to deteriorate due to insufficient medicinesupply. Domestic inflation in Argentina will continue to erode the competitiveness of its pharmaceuticalexports, minimising gains from a ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Colombia Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
... cuts. Less stringent bioequivalence regulationswill also undermine sale growth posted by branded generic drugmakers. However, Colombia's relativelyadvanced drug reimbursement system will still offer revenue-generating opportunities for multinationals incomparison with other second-tier Latin American pharmaceutical markets. ...  |  read more...
USD 1,295
Pharmaceuticals: BRIC (Brazil, Russia, India, China) Industry Guide
5/9/2014 | published by: MarketLine
... descriptions of the leading companies including key financial metrics and analysis of competitive pressures within the market. Features and benefits Save time carrying out entry-level research by identifying the size, growth, and leading players in ...  |  read more...
USD 995
Venezuela Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
... and effective communication with the Venezuelan government are vital for the survivalof domestic pharmaceutical companies. As the Venezuelan government tries to increase access tomedicines, more co-ordination with drug producers to address these issues will become ...  |  read more...
USD 1,295
Brazil Pharmaceuticals and Healthcare Report Q2 2014
3/19/2014 | published by: Business Monitor International
... opportunities for drugmakers and healthcare serviceproviders. However, given the Brazilian government's protectionist measures in the pharmaceutical sector,we believe local drugmakers will outpace multinationals. Headline Expenditure Projections Pharmaceuticals: BRL57.0bn (US$26.4bn) in 2013 to BRL61.6bn (US$26.2bn) in ...  |  read more...
USD 1,295
Chile Pharmaceuticals and Healthcare Report Q2 2014
3/19/2014 | published by: Business Monitor International
... the country. The tightenedbioequivalent regulations will boost genuine medicine sales and force similares out of the market. However,we believe the current lack of vigilance in bioequivalence regulations in Chile has allowed the proliferationof low quality ...  |  read more...
USD 1,295
Peru Pharmaceuticals and Healthcare Report Q2 2014
3/12/2014 | published by: Business Monitor International
... companies can generate rapid sales growth due to the lack of mandatory medicine pricingsystem in Peru. More stringent quality controls, relatively weak domestic pharmaceutical industry, ongoingliberalisation of bilateral trade agreements and the recognition of 'High ...  |  read more...
USD 1,295
The Pharmaceutical Market: Brazil
3/11/2014 | published by: Espicom Healthcare Intelligence
... innovative, high-tech products. The government i s increasing ly invest ing in the healthcare sector and pharmaceutical industry to reduce the financial burden of diseases , and the country's private healthcare sectors provide opportunities for ...  |  read more...
USD 1,295
Argentina Pharmaceuticals and Healthcare Report Q2 2014
2/21/2014 | published by: Business Monitor International
... biotechnology sector remain scant, are scattered across the country and thereis a lack of continuity in comparison with its neighbour Brazil. The long-term absence of orthodoxeconomic policy in the country will also hinder private investment ...  |  read more...
USD 1,295
Colombia Pharmaceuticals and Healthcare Report Q2 2014
2/21/2014 | published by: Business Monitor International
... constrained over the comingyears. On the positive side, we expect volume sales will be boosted and partially offset the negative impactsof further drug price cuts. Colombia's relatively advanced drug reimbursement system will still offerrevenue-generating opportunities ...  |  read more...
USD 1,295
PharmaSphere: Pharmaceutical and Healthcare Deal Trends in Latin America: 2008 - 2012
1/31/2014 | published by: GlobalData
... that took place in the region during the last decade. The type of deals covered in the report include Mergers & Acquisitions (M&A), Licensing and Collaboration & Partnerships. The report also provides understanding on the ...  |  read more...
USD 2,995
Pharmaceuticals in Brazil: ISIC 2423
1/27/2014 | published by: Euromonitor International
... at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing ...  |  read more...
USD 600
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil
10/14/2013 | published by: GlobalData
... information and analysis regarding the healthcare, regulatory and reimbursement landscape in Brazil. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, ...  |  read more...
USD 1,995
Chemical & Pharmaceutical Plant Construction in Colombia to 2017: Market Databook
8/28/2013 | published by: Timetric
... chemical & pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the ...  |  read more...
USD 500
PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022
7/31/2013 | published by: GlobalData
... The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more than ...  |  read more...
USD 4,995
BRIC: pharmahandbook
6/1/2013 | published by: VOI Consulting
... on the structural, regulatory and commercial aspects of the biopharmaceutical markets in each country, pharmahandbook’s 2013 BRIC report provides you with what you need to know in order to capi-talize on these vitally important but ...  |  read more...
USD 905
Chemical & Pharmaceutical Plant Construction in Chile to 2017: Market Databook
5/13/2013 | published by: Timetric
... chemical & pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the ...  |  read more...
USD 500
Healthcare, Regulatory and Reimbursement Landscape - Argentina
4/22/2013 | published by: GlobalData
... regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the ...  |  read more...
USD 1,995
< prev 1    3  4